These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31545126)
1. Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension. Sadushi-Kolici R; Lang IM Expert Rev Respir Med; 2019 Sep; ():1-7. PubMed ID: 31545126 [No Abstract] [Full Text] [Related]
2. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Sadushi-Kolici R; Jansa P; Kopec G; Torbicki A; Skoro-Sajer N; Campean IA; Halank M; Simkova I; Karlocai K; Steringer-Mascherbauer R; Samarzija M; Salobir B; Klepetko W; Lindner J; Lang IM Lancet Respir Med; 2019 Mar; 7(3):239-248. PubMed ID: 30477763 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension. Swisher JW; Elliott D Respir Med Case Rep; 2017; 20():45-47. PubMed ID: 27942445 [TBL] [Abstract][Full Text] [Related]
4. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension. Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326 [TBL] [Abstract][Full Text] [Related]
5. The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil. Jansa P; Kopeć G; Torbicki A; Sadushi-Kolici R; Campean IA; Halank M; Simkova I; Steringer-Mascherbauer R; Salobir B; Klepetko W; Lindner J; Lang IM Pulm Circ; 2023 Jul; 13(3):e12274. PubMed ID: 37609358 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Lang I; Gomez-Sanchez M; Kneussl M; Naeije R; Escribano P; Skoro-Sajer N; Vachiery JL Chest; 2006 Jun; 129(6):1636-43. PubMed ID: 16778286 [TBL] [Abstract][Full Text] [Related]
7. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Tanabe N; Sugiura T; Tatsumi K Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639 [TBL] [Abstract][Full Text] [Related]
8. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. Skoro-Sajer N; Bonderman D; Wiesbauer F; Harja E; Jakowitsch J; Klepetko W; Kneussl MP; Lang IM J Thromb Haemost; 2007 Mar; 5(3):483-9. PubMed ID: 17319903 [TBL] [Abstract][Full Text] [Related]
10. Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension. Ghofrani HA; D'Armini AM; Kim NH; Mayer E; Simonneau G Respir Med; 2021 Feb; 177():106293. PubMed ID: 33465538 [TBL] [Abstract][Full Text] [Related]
11. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension. Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685 [TBL] [Abstract][Full Text] [Related]
12. Transition of Intravenous Treprostinil to Oral Therapy in a Patient with Functional Class IV Chronic Thromboembolic Pulmonary Hypertension. Thurber KM; Williams BM; Bates RE; Frantz RP Pharmacotherapy; 2017 Aug; 37(8):e76-e81. PubMed ID: 28513869 [TBL] [Abstract][Full Text] [Related]